Written Q&A  |
Proteins & Antibodies

Bioconjugation and New Target Discovery

24 April 2019
Thomas Hoeg-Jensen, Scientific Director, Novo Nordisk A/S

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Biologics